Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global threat with an ever-increasing death toll even after a year on. Hence, the rapid identification of infected individuals with diagnostic tests continues to be crucial in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Kok Gan, Ang, Geik Yong, Yu, Choo Yee, Yean, Chan Yean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623262/
https://www.ncbi.nlm.nih.gov/pubmed/34833086
http://dx.doi.org/10.3390/life11111210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623262/
https://www.ncbi.nlm.nih.gov/pubmed/34833086
http://dx.doi.org/10.3390/life11111210

Ejemplares similares